NDC 0713-0937 – Cevimeline hydrochloride

Cevimeline Hydrochloride 30 mg/1 · Capsule · Oral

Human Prescription Drug

Product NDC0713-0937

Product details

Brand name
Cevimeline hydrochloride
Generic name
Cevimeline hydrochloride
Labeler
Cosette Pharmaceuticals, Inc.
Dosage form
Capsule
Route
Oral
Marketing category
NDA · NDA020989
Marketed since
January 3, 2023
Listing expires
December 31, 2026
Pharmacologic class
Cholinergic Receptor Agonist

Active ingredients

Uses, dosage, side effects and warnings for Cevimeline hydrochloride →

Package NDC codes (1)

Package NDCDescriptionSince
0713-0937-01100 CAPSULE in 1 BOTTLE, PLASTIC (0713-0937-01)Jan 3, 2023

Other Cevimeline hydrochloride products